FDA Roundup: March 15, 2024

Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA published its new paper, “Artificial Intelligence and Medical Products: How CBER, CDER, CDRH, and OCP are Working Together,” which outlines specific focus areas regarding the development and use of AI across the medical product lifecycle. The paper helps further align and streamline the agency’s work in AI. Read more about the agency’s AI initiatives on our website. Today, the FDA published the “Catching Up with Califf: Harnessing the Potential of Artificial Intelligence,” by Robert M. Califf, M.D., Commissioner of Food and Drugs. The Commissioner discusses how the ...